Yamanaka M - Search Results

1

Toxicity profile of benzo[a]pyrene in the male LacZ transgenic mouse (MutaMouse) following oral administration for 5 consecutive days.

Hakura A, Sonoda J, Tsutsui Y, Mikami T, Imade T, Shimada M, Yaguchi S, Yamanaka M, Tomimatsu M, Tsukidate K. Hakura A, et al. Among authors: yamanaka m. Regul Toxicol Pharmacol. 1998 Jun;27(3):273-9. doi: 10.1006/rtph.1998.1218. Regul Toxicol Pharmacol. 1998. PMID: 9693078

2

Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.

Negi S, Yamanaka M, Sugiyama I, Komatsu Y, Sasho M, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al. Negi S, et al. Among authors: yamanaka m. J Antibiot (Tokyo). 1994 Dec;47(12):1507-25. doi: 10.7164/antibiotics.47.1507. J Antibiot (Tokyo). 1994. PMID: 7844045 Free article.

3

Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins.

Negi S, Sasho M, Yamanaka M, Sugiyama I, Komatsu Y, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al. Negi S, et al. Among authors: yamanaka m. J Antibiot (Tokyo). 1994 Dec;47(12):1526-40. doi: 10.7164/antibiotics.47.1526. J Antibiot (Tokyo). 1994. PMID: 7844046 Free article.

4

Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.

Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Yamanaka M, et al. Diabetes Obes Metab. 2007 Nov;9(6):879-88. doi: 10.1111/j.1463-1326.2006.00675.x. Diabetes Obes Metab. 2007. PMID: 17924870

5

Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice.

Tsuchida A, Nonomura T, Nakagawa T, Itakura Y, Ono-Kishino M, Yamanaka M, Sugaru E, Taiji M, Noguchi H. Tsuchida A, et al. Among authors: yamanaka m. Diabetes Obes Metab. 2002 Jul;4(4):262-9. doi: 10.1046/j.1463-1326.2002.00206.x. Diabetes Obes Metab. 2002. PMID: 12099975

6

Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.

Nakagawa T, Ono-Kishino M, Sugaru E, Yamanaka M, Taiji M, Noguchi H. Nakagawa T, et al. Among authors: yamanaka m. Diabetes Metab Res Rev. 2002 May-Jun;18(3):185-91. doi: 10.1002/dmrr.290. Diabetes Metab Res Rev. 2002. PMID: 12112936 Review.

7

Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.

Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Yamanaka M, et al. Metabolism. 2006 Oct;55(10):1286-92. doi: 10.1016/j.metabol.2006.04.017. Metabolism. 2006. PMID: 16979397

8

Brain-derived neurotrophic factor (BDNF) prevents the development of diabetes in prediabetic mice.

Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Taiji M. Yamanaka M, et al. Biomed Res. 2008 Jun;29(3):147-53. doi: 10.2220/biomedres.29.147. Biomed Res. 2008. PMID: 18614848 Free article.

9

Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.

Nakagawa T, Ogawa Y, Ebihara K, Yamanaka M, Tsuchida A, Taiji M, Noguchi H, Nakao K. Nakagawa T, et al. Among authors: yamanaka m. Int J Obes Relat Metab Disord. 2003 May;27(5):557-65. doi: 10.1038/sj.ijo.0802265. Int J Obes Relat Metab Disord. 2003. PMID: 12704399

10

Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.

Yamanaka M, Tsuchida A, Nakagawa T, Nonomura T, Ono-Kishino M, Sugaru E, Noguchi H, Taiji M. Yamanaka M, et al. Diabetes Obes Metab. 2007 Jan;9(1):59-64. doi: 10.1111/j.1463-1326.2006.00572.x. Diabetes Obes Metab. 2007. PMID: 17199719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,093 results

Search Page

Filters